Top News

Jun 20, 2018
By BioPharm International Editors
The acquisition is expected to strengthen Sanofi’s R&D strategy with Ablynx’s nanobody technology platform.
Jun 13, 2018
By BioPharm International Editors
Bayer completed its acquisition of Monsanto, the largest in Bayer’s history.
May 30, 2018
By BioPharm International Editors
Bayer received conditional approval from the Antitrust Division of the United States Department of Justice to acquire Monsanto in a deal worth $66 billion.
May 16, 2018
By BioPharm International Editors
The acquisition is expected to strengthen Novartis’ gene therapy pipeline.
May 15, 2018
By BioPharm International Editors
Eli Lilly will acquire ARMO BioSciences to strengthen Lilly's immuno-oncology program.
May 14, 2018
President Donald Trump announced his strategy for making prescription medicines more affordable and accessible in the United States.
May 09, 2018
By BioPharm International Editors
Takeda expands its global and therapy base with announced acquisition of Shire.
May 09, 2018
By BioPharm International Editors
Johnson & Johnson’s Janssen Biotech will acquire biotechnology company BeneVir Biopharm to strengthen Janssen’s immunotherapy platform.
May 07, 2018
Smaller review divisions will bring experts closer to decision processes and reduce bottlenecks, FDA leaders say.
May 01, 2018
By BioPharm International Editors
Fresenius Kabi claims that Akorn failed to fulfill several closing conditions.
native1_300x100
lorem ipsum